Living With CML

CML News From ASH: Patient Advocate Perspective

As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Jan Geissler, a patient advocate and director of the European Patients Academy on Therapeutic Innovation, joined Patient Power to share his perspective on the latest news in chronic myeloid leukemia (CML).

Jan Geissler, Esther Schorr

Living With CML

Patient Advocate Perspective: Stopping CML Treatment After Remission

During the 2014 American Society of Hematology (ASH) annual meeting, Patient Power caught up with our friend, Jan Geissler, a patient advocate living with CML 2001. Jan shares his perspective on the future of CML.